文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

资源匮乏地区HIV护理失访的时间依赖性预测因素:一种竞争风险方法。

Time-dependent predictors of loss to follow-up in HIV care in low-resource settings: A competing risks approach.

作者信息

Gebre Tamrat Endebu, Taye Girma, Deressa Wakgari

机构信息

Department of Epidemiology and Biostatistics, School of Public Health, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia.

出版信息

PLoS One. 2025 Jul 24;20(7):e0329132. doi: 10.1371/journal.pone.0329132. eCollection 2025.


DOI:10.1371/journal.pone.0329132
PMID:40705795
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12289015/
Abstract

Loss to follow-up (LTFU) remains a major challenge in HIV care, particularly in resource-limited settings. While several studies have identified its predictors, many have neglected the competing risks of transfer out and death, as well as the dynamic influence of these predictors over time. A retrospective cohort study was conducted among adult HIV patients who initiated antiretroviral therapy (ART) between 2019 and 2024. LTFU was a primary outcome, whereas transfer out and death were competing risks. A Fine‒Gray subdistribution hazard ratio (SHR) regression analysis identified LTFU predictors within a competing risk framework. An extended SHR model with a time‒covariate interaction term was used to examine the predictors' time‒varying effects on LTFU risk. Data analysis was performed via STATA 17 and Python 3.9. In a cohort of 4,135 HIV patients (8,521.54 person-years of follow-up), the overall incidence of LTFU was 13.10 per 100 person-years (95% CI: 12.35-13.89), with cumulative risks of 15%, 25%, and 35% at 1, 3, and 5 years post-ART, respectively. The predictors of LTFU included younger age (15-24 years: aSHR = 1.51), male sex (aSHR = 1.24), incomplete address details (aSHR = 1.72), noninitiation/noncompletion of TPT (aSHR = 2.16), poor adherence (aSHR = 2.54), and undernutrition (aSHR = 2.03). While younger age (e.g., 15-24 years) was associated with an increased risk of LTFU at baseline (baseline aSHR = 1.36, p = 0.014), this association diminished over time (interaction aSHR = 0.54, p = 0.001). Undernutrition consistently predicted LTFU (baseline aSHR = 1.64, p < 0.001), with no significant time-dependent effect (interaction aSHR = 1.01, p = 0.903). In conclusion, this study highlights the high incidence of LTFU among HIV patients and its key predictors. Notably, age has a significant time-dependent effect, with its influence on the risk of LTFU being most pronounced during the early stage of ART initiation, whereas nutritional status remains a consistent predictor of LTFU over time.

摘要

失访在艾滋病护理中仍然是一项重大挑战,在资源有限的环境中尤为如此。虽然多项研究已确定了失访的预测因素,但许多研究都忽略了转出和死亡的竞争风险,以及这些预测因素随时间的动态影响。对2019年至2024年开始接受抗逆转录病毒治疗(ART)的成年艾滋病患者进行了一项回顾性队列研究。失访是主要结局,而转出和死亡是竞争风险。采用Fine-Gray亚分布风险比(SHR)回归分析在竞争风险框架内确定失访的预测因素。使用带有时间协变量交互项的扩展SHR模型来检验预测因素对失访风险的时间变化影响。数据分析通过STATA 17和Python 3.9进行。在一个包含4135名艾滋病患者的队列中(随访8521.54人年),失访的总体发生率为每100人年13.10例(95%置信区间:12.35 - 13.89),在ART治疗后1年、3年和5年的累积风险分别为15%、25%和35%。失访的预测因素包括年龄较小(15 - 24岁:aSHR = 1.51)、男性(aSHR = 1.24)、地址信息不完整(aSHR = 1.72)、未开始/未完成结核病预防性治疗(aSHR = 2.16)、依从性差(aSHR = 2.54)和营养不良(aSHR = 2.03)。虽然年龄较小(如15 - 24岁)在基线时与失访风险增加相关(基线aSHR = 1.36,p = 0.014),但这种关联随时间减弱(交互作用aSHR = 0.54,p = 0.001)。营养不良一直是失访的预测因素(基线aSHR = 1.64,p < 0.001),且无显著的时间依赖性效应(交互作用aSHR = 1.01,p = 0.903)。总之,本研究突出了艾滋病患者中失访的高发生率及其关键预测因素。值得注意的是,年龄具有显著的时间依赖性效应,其对失访风险的影响在ART治疗开始的早期最为明显,而营养状况一直是失访的预测因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5806/12289015/75e584620e63/pone.0329132.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5806/12289015/75e584620e63/pone.0329132.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5806/12289015/75e584620e63/pone.0329132.g001.jpg

相似文献

[1]
Time-dependent predictors of loss to follow-up in HIV care in low-resource settings: A competing risks approach.

PLoS One. 2025-7-24

[2]
Retrospective cohort study of predictors of loss to follow up among adolescents and young adults living with HIV on ART in Dar es Salaam, Tanzania, 2015-2019.

BMC Infect Dis. 2025-7-1

[3]
Determinants of loss to follow-up among people living with HIV receiving antiretroviral therapy in a universal test and treat setting: A retrospective cohort study in Nepal.

Public Health Pract (Oxf). 2025-6-26

[4]
Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women.

Cochrane Database Syst Rev. 2010-3-17

[5]
Does Augmenting Irradiated Autografts With Free Vascularized Fibula Graft in Patients With Bone Loss From a Malignant Tumor Achieve Union, Function, and Complication Rate Comparably to Patients Without Bone Loss and Augmentation When Reconstructing Intercalary Resections in the Lower Extremity?

Clin Orthop Relat Res. 2025-6-26

[6]
Optimisation of antiretroviral therapy in HIV-infected children under 3 years of age.

Cochrane Database Syst Rev. 2014-5-22

[7]
Task shifting from doctors to non-doctors for initiation and maintenance of antiretroviral therapy.

Cochrane Database Syst Rev. 2014-7-1

[8]
Joint modeling of predictors of adverse drug reactions and viral load changes over time among adult patients on ART at Nigist Eleni Mohammed Memorial comprehensive specialized hospital, central Ethiopia.

BMC Infect Dis. 2025-7-12

[9]
Incidence and predictors of pregnancy among reproductive-age women in an ART clinic of public health facilities in Arsi zone, southeastern ethiopia: a five-year retrospective cohort study.

BMC Womens Health. 2025-7-16

[10]
Improving estimators of HIV mortality and retention in care by linking clinical cohort data with national registries in Mexico.

BMC Public Health. 2025-7-17

本文引用的文献

[1]
Enhancing Therapy Adherence: Impact on Clinical Outcomes, Healthcare Costs, and Patient Quality of Life.

Medicina (Kaunas). 2025-1-17

[2]
Enhancing engagement in HIV care among adolescents and young adults: A focus on phone-based navigation and relationship building to address barriers in HIV care.

PLOS Glob Public Health. 2025-1-9

[3]
Prevalence, Predictors, and Outcomes of HIV Care in HIV-Positive Clients Entering HIV Care With Advanced HIV Disease in Sub-Saharan Africa 2010-2022: Systematic Review and Meta-Analysis.

Health Sci Rep. 2024-12-24

[4]
Competing Risks in Clinical Trials: Do They Matter and How Should We Account for Them?

J Am Coll Cardiol. 2024-9-10

[5]
Mapping the spatial disparities of HIV prevalence in Ethiopian zones using the generalized additive model.

Sci Rep. 2024-3-14

[6]
Determinants of Loss to Follow Up Among Adult People Living with HIV Enrolled in Antiretroviral Therapy in West Wollega Public Hospitals, Oromia, Ethiopia.

HIV AIDS (Auckl). 2024-2-26

[7]
Challenges and barriers to HIV care engagement and care cascade: viewpoint.

Front Reprod Health. 2023-7-20

[8]
Incidence and Predictors of Loss to Follow-Up Among Adults on Antiretroviral Therapy in South Gondar Governmental Hospitals, Ethiopia: Retrospective Cohort Study.

J Multidiscip Healthc. 2023-6-22

[9]
Predictors of the observed high prevalence of loss to follow-up in ART-experienced adult PLHIV: a retrospective longitudinal cohort study in the Tanga Region, Tanzania.

BMC Infect Dis. 2023-2-14

[10]
Incidence and predictors of loss to follow-up among adult HIV-infected patients taking antiretroviral therapy at North Shewa zone public Hospitals, Northeast Ethiopia: A retrospective follow-up study.

Afr Health Sci. 2022-6

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索